Literature DB >> 33415521

Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Yoshio Araki1, Kinya Yokoyama2, Kenji Uda2, Fumiaki Kanamori2, Michihiro Kurimoto2, Yoshiki Shiba2, Takashi Mamiya2, Masahiro Nishihori2, Takashi Izumi2, Masaki Sumitomo3, Sho Okamoto4, Kota Matsui5, Ryo Emoto5, Toshihiko Wakabayashi2, Shigeyuki Matsui5, Atsushi Natsume2.   

Abstract

Stroke and neurological outcomes in the early phase following revascularization for moyamoya disease (MMD) may depend on the patient's age. In this study, an age-stratified comparative analysis was performed to clarify this issue. We reviewed 105 MMD patients who underwent 179 revascularization surgeries. The demographic characteristics were collected in four age groups (≤ 5 and 6-17 years for pediatric patients and 18-49 and ≥ 50 years for adults). Additionally, we assessed the incidence of subsequent stroke and deterioration of modified Rankin Scale (mRS) score. Then, we evaluated predictors of postoperative stroke and mRS deterioration using logistic regression. The mean patient age was 26.2 ± 18.5 years. No significant difference in the incidence of postoperative stroke was observed between age groups; however, the incidence tended to be increased among patients aged ≤ 5 years (17.9%) and patients aged ≥ 50 years (16.7%). Deterioration of mRS scores was significantly associated with ages ≤ 5 years (17.9%) and ≥ 50 years (11.1%). Logistic regression showed that posterior cerebral artery involvement (odds ratio [OR], 4.6) and postoperative transient neurological events (TNEs) (OR, 5.93) were risk factors for postoperative stroke. Age ≤ 5 years (OR, 9.73), postoperative TNEs (OR, 7.38), and postoperative stroke (OR, 49) were identified as predictors of unfavorable neurological outcomes. The novel feature of this comparative analysis by age group is that membership in the early-childhood MMD patient group (under 5 years old) was an independent risk factor for unfavorable short-term neurological outcomes and was mainly associated with the incidence of postoperative severe cerebral infarction.

Entities:  

Keywords:  Moyamoya disease; Neurological outcomes; Postoperative stroke; Revascularization surgeries

Year:  2021        PMID: 33415521     DOI: 10.1007/s10143-020-01459-0

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  33 in total

1.  Cognitive function of patients with adult moyamoya disease.

Authors:  Yoshio Araki; Yasushi Takagi; Keita Ueda; Shiho Ubukata; Junko Ishida; Takeshi Funaki; Takayuki Kikuchi; Jun C Takahashi; Toshiya Murai; Susumu Miyamoto
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-06-21       Impact factor: 2.136

2.  Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome.

Authors:  Jung Won Choi; Sangjoon Chong; Ji Hoon Phi; Ji Yeoun Lee; Hee-Soo Kim; Jong Hee Chae; Joongyub Lee; Seung-Ki Kim
Journal:  World Neurosurg       Date:  2019-12-21       Impact factor: 2.104

3.  Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China.

Authors:  Xiang-Yang Bao; Lian Duan; Wei-Zhong Yang; De-Sheng Li; Wei-Jian Sun; Zheng-Shan Zhang; Rui Zong; Cong Han
Journal:  Cerebrovasc Dis       Date:  2015-01-06       Impact factor: 2.762

4.  Long-Term Outcome After Conservative Treatment and Direct Bypass Surgery of Moyamoya Disease at Late Suzuki Stage.

Authors:  Peicong Ge; Qian Zhang; Xun Ye; Xingju Liu; Xiaofeng Deng; Hao Li; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  World Neurosurg       Date:  2017-03-30       Impact factor: 2.104

5.  Long-term outcomes after combined revascularization surgery in adult moyamoya disease.

Authors:  Won-Sang Cho; Jeong Eun Kim; Chang Hyeun Kim; Seung Pil Ban; Hyun-Seung Kang; Young Je Son; Jae Seung Bang; Chul-Ho Sohn; Jin Chul Paeng; Chang Wan Oh
Journal:  Stroke       Date:  2014-09-02       Impact factor: 7.914

6.  Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.

Authors:  Miki Fujimura; Hiroaki Shimizu; Takashi Inoue; Shunji Mugikura; Atsushi Saito; Teiji Tominaga
Journal:  Neurosurgery       Date:  2011-04       Impact factor: 4.654

7.  Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.

Authors:  Takeshi Funaki; Jun C Takahashi; Yasushi Takagi; Takayuki Kikuchi; Kazumichi Yoshida; Takafumi Mitsuhara; Hiroharu Kataoka; Tomohisa Okada; Yasutaka Fushimi; Susumu Miyamoto
Journal:  J Neurosurg       Date:  2014-11-28       Impact factor: 5.115

8.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

9.  Clinical presentation, progression, and treatment outcomes of moyamoya disease in the elderly.

Authors:  Raghav Gupta; Justin M Moore; Nimer Adeeb; Christoph J Griessenauer; Apar S Patel; Michelle H Chua; Ajith J Thomas; Christopher S Ogilvy
Journal:  Acta Neurochir (Wien)       Date:  2016-10-18       Impact factor: 2.216

10.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

View more
  4 in total

1.  Protective Effects of Aquaporin-4 Deficiency on Longer-term Neurological Outcomes in a Mouse Model.

Authors:  Xiaosong Liu; Yingxin Xie; Xiangdong Wan; Jianliang Wu; Zhenzeng Fan; Lijun Yang
Journal:  Neurochem Res       Date:  2021-03-02       Impact factor: 3.996

2.  Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.

Authors:  Yoshio Araki; Takashi Mamiya; Naotoshi Fujita; Kenji Uda; Kinya Yokoyama; Fumiaki Kanamori; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuch; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Takafumi Tanei; Masaki Sumitomo; Sho Okamoto; Takashi Izumi; Katsuhiko Kato; Ryuta Saito
Journal:  Neurosurg Rev       Date:  2022-03-23       Impact factor: 3.042

3.  Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease.

Authors:  Xiaofan Yu; Peicong Ge; Yuanren Zhai; Rong Wang; Yan Zhang; Dong Zhang
Journal:  Front Neurol       Date:  2022-07-26       Impact factor: 4.086

4.  Paradoxical symptomatic cerebral blood flow decreases after combined revascularization surgery for patients with pediatric moyamoya disease: illustrative case.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Kai Takayanagi; Kazuki Ishii; Masahiro Nishihori; Kazuhito Takeuchi; Kuniaki Tanahashi; Yuichi Nagata; Yusuke Nishimura; Sho Okamoto; Masaki Sumitomo; Takashi Izumi; Ryuta Saito
Journal:  J Neurosurg Case Lessons       Date:  2022-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.